Cargando…

Methylprednisolone, venous thromboembolism, and association with heparin to 30 days in hospital survival in severe Covid-19 pneumonia

BACKGROUND: Mortality in severe COVID-19 pneumonia is associated with thrombo-inflammation. Corticosteroids are given to attenuate the inflammation, but they are associated with thrombosis. The aims of this study were to determine the risk of venous thromboembolism between no methylprednisolone and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Go, Ronaldo C., Nyirenda, Themba, Bojarian, Maryam, Hosseini, Davood K., Rahim, Mehek, Kim, Kevin, Rose, Keith M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8731184/ https://www.ncbi.nlm.nih.gov/pubmed/34986821 http://dx.doi.org/10.1186/s12890-021-01810-1

Ejemplares similares

Racial/ethnic disparities on inflammation and response to methylprednisolone in severe COVID-19 pneumonia
por: Go, Ronaldo C., et al.
Publicado: (2022)

Hydroxychloroquine, azithromycin and methylprednisolone and in hospital survival in severe COVID-19 pneumonia
por: Go, Ronaldo C., et al.
Publicado: (2022)

Methylprednisolone and 60 Days in Hospital Survival in Coronavirus Disease 2019 Pneumonia
por: Go, Ronaldo C., et al.
Publicado: (2021)

Cirrhosis is Associated with an Increased 30-Day Mortality After Venous Thromboembolism
por: Søgaard, Kirstine Kobberøe, et al.
Publicado: (2015)

RACIAL/ETHNIC DISPARITIES ON INFLAMMATORY MARKERS IN SEVERE COVID-19 PNEUMONIA
por: GO, R., et al.
Publicado: (2022)

Safety of heparin prophylaxis for venous thromboembolism in patients with neurotrauma
por: Puri, G, et al.
Publicado: (2010)

Low-molecular-weight heparins in the treatment of venous thromboembolism
por: Ageno , Walter, et al.
Publicado: (2000)

High Burden of 30‐Day Readmissions After Acute Venous Thromboembolism in the United States
por: Secemsky, Eric A., et al.
Publicado: (2018)

Why differentiate low molecular weight heparins for venous thromboembolism?
por: Fareed, Jawed, et al.
Publicado: (2007)

Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism
por: Smythe, Maureen A., et al.
Publicado: (2016)

Heparin/methylprednisolone: Lack of efficacy: case report
Publicado: (2021)

Colchicine as an adjunct to heparin for prophylaxis of venous thromboembolism in patients with COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2021)

Impact of liver cirrhosis on ST-elevation myocardial infarction related shock and interventional management, a nationwide analysis
por: Dar, Sophia Haroon, et al.
Publicado: (2022)

The use of fondaparinux for the treatment of venous thromboembolism in a patient with heparin-induced thombocytopenia and thrombosis caused by heparin flushes
por: Spyropoulos, Alex C, et al.
Publicado: (2008)

Spontaneous Heparin-Induced Thrombocytopenia and Venous Thromboembolism following Total Knee Arthroplasty
por: Baker, Kevin, et al.
Publicado: (2017)

Venous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism Registry
por: Bikdeli, Behnood, et al.
Publicado: (2022)

Unfractionated heparin or low-molecular-weight heparin for venous thromboembolism prophylaxis after hepatic resection: A meta-analysis
por: Zhang, Wentao, et al.
Publicado: (2022)

Evaluation of the Effects of E-Learning on Nurses’ Behavior and Knowledge Regarding Venous Thromboembolism
por: Bahrambeygi, Fatemeh, et al.
Publicado: (2019)

Coexistence of Antiphospholipid Syndrome and Heparin-Induced Thrombocytopenia in a Patient with Recurrent Venous Thromboembolism
por: Adediran, Samuel, et al.
Publicado: (2017)

Rivaroxaban versus Low-Molecular-Weight Heparin for Venous Thromboembolism in Gastrointestinal and Pancreatobiliary Cancer
por: Lee, Jang Ho, et al.
Publicado: (2019)

Effectiveness and Safety of Rivaroxaban and Low Molecular Weight Heparin in Cancer-Associated Venous Thromboembolism
por: Coleman, Craig I., et al.
Publicado: (2023)

Association of Inferior Vena Cava Filter Placement for Venous Thromboembolic Disease and a Contraindication to Anticoagulation With 30-Day Mortality
por: Turner, Tyson E., et al.
Publicado: (2018)

Efficacy and safety of a 30-day methylprednisolone treatment protocol for subacute thyroiditis: a prospective study
por: Bajuk Studen, Katica, et al.
Publicado: (2023)

Cancer-Associated Venous Thromboembolism: A Practical Review Beyond Low-Molecular-Weight Heparins
por: Smrke, Alannah, et al.
Publicado: (2017)

Aspirin/low-molecular-weight-heparins/methylprednisolone: Lack of efficacy: case report
Publicado: (2022)

Prevention and treatment of venous thromboembolism with low-molecular-weight heparins: Clinical implications of the recent European guidelines
por: Prandoni, Paolo
Publicado: (2008)

Dealing with thrombocytopenia during anticoagulation with heparins for active venous thromboembolism: a play-it-safe practical approach
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2011)

The economic impact of enoxaparin versus unfractionated heparin for prevention of venous thromboembolism in acute ischemic stroke patients
por: Pineo, Graham F, et al.
Publicado: (2012)

Prophylaxis of cancer-associated venous thromboembolism with low-molecular-weight heparin-tinzaparin: Real world evidence
por: Christopoulou, Athina, et al.
Publicado: (2022)

Thirty-day readmissions due to Venous thromboembolism in patients discharged with syncope
por: Siddappa Malleshappa, Sudeep K., et al.
Publicado: (2020)

Coagulopathy, thromboembolic complications, and the use of heparin in COVID-19 pneumonia
por: Costanzo, Luca, et al.
Publicado: (2020)

ABO BLOOD TYPES AND INFLAMMATORY MARKERS IN COVID-19 PNEUMONIA
por: GO, R., et al.
Publicado: (2022)

Do pregnant women have a higher risk for venous thromboembolism following air travel?
por: Izadi, Morteza, et al.
Publicado: (2015)

Venous thromboembolism /
por: Hirsh, Jack, 1935-
Publicado: (1981)

Heparin based prophylaxis to prevent venous thromboembolic events and death in patients with cancer - a subgroup analysis of CERTIFY
por: Haas, Sylvia, et al.
Publicado: (2011)

What's new in emergencies, trauma, and shock? Heparin in severe traumatic brain injury: Beyond venous thromboembolism prevention?
por: Masotti, Luca, et al.
Publicado: (2014)

The Efficacy of Low Molecular Weight Heparin for the Prevention of Venous Thromboembolism after Hip Fracture Surgery in Korean Patients
por: Kim, Kwang-Kyoun, et al.
Publicado: (2016)

Rivaroxaban treatment for cancer-associated venous thromboembolism in a patient with heparin-induced thrombocytopenia: a case report
por: Le, Ke-Jia, et al.
Publicado: (2019)

Evaluation of anti-Xa levels in patients with venous thromboembolism within the first 48 h of anticoagulation with unfractionated heparin
por: Nguyen, Lily, et al.
Publicado: (2023)

Competing Risk Analysis for Evaluation of Dalteparin Versus Unfractionated Heparin for Venous Thromboembolism in Medical-Surgical Critically Ill Patients
por: Li, Guowei, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tmg1mdavd9vjvk5r5q7afp150b